Trial Condition(s):

N/A

Relative bioavailability of rivaroxaban under different administration conditions

Bayer Identifier:

17861

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

2015-000082-31

EU CT Number:

Not Available

Study Completed

Trial Purpose

Inclusion Criteria

No Inclusion Criteria Available

Exclusion Criteria

No Exclusion Criteria Available

Trial Summary

Enrollment Goal

Trial Dates

March2015

June2015

Phase

Could I receive a placebo?

Products

Xarelto (Rivaroxaban, BAY59-7939)

Accepts Healthy Volunteers

Yes

Where to Participate

Locations

Status

Locations	Status
Locations Investigative Site Mannheim, Germany, 68167	Status Completed	Contact Us: E-mail: [email protected] Phone: Not Available

Locations

Status

Locations

Investigative Site

Mannheim, Germany, 68167

Status

Completed

Contact Us:

E-mail: [email protected]

Phone: Not Available

N/A

Bayer Identifier:

ClinicalTrials.gov Identifier:

EudraCT Number:

EU CT Number:

Trial Purpose

Key Participation Requirements

sex

age

18 Years

55 Years

Inclusion Criteria

Exclusion Criteria

Inclusion Criteria

Exclusion Criteria

Trial Summary

Enrollment Goal

Trial Dates

Phase

Could I receive a placebo?

Products

Accepts Healthy Volunteers

Where to Participate

For details, please refer to trial results

Additional Information